173 related articles for article (PubMed ID: 23981338)
41. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
Fu J; Chen Z; Cen J; Ruan C
Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
[TBL] [Abstract][Full Text] [Related]
42. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
43. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
[TBL] [Abstract][Full Text] [Related]
44. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
[TBL] [Abstract][Full Text] [Related]
45. Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo.
Li M; de Graaf IA; de Jager MH; Groothuis GM
Toxicol In Vitro; 2015 Aug; 29(5):1070-8. PubMed ID: 25917215
[TBL] [Abstract][Full Text] [Related]
46. Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Cen J; Liu L; He L; Ji BS
Drug Res (Stuttg); 2013 Aug; 63(8):429-34. PubMed ID: 23720244
[TBL] [Abstract][Full Text] [Related]
47. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
Yigitaslan S; Erol K; Cengelli C
Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
[TBL] [Abstract][Full Text] [Related]
48. A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: implications for intestinal pH and effects on drug absorption.
Mitra P; Audus K; Williams G; Yazdanian M; Galinis D
J Pharm Sci; 2011 Oct; 100(10):4258-68. PubMed ID: 21538355
[TBL] [Abstract][Full Text] [Related]
49. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and beta-methyldigoxin in rats.
Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
J Pharm Sci; 2003 Jul; 92(7):1455-63. PubMed ID: 12820149
[TBL] [Abstract][Full Text] [Related]
50. Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids.
Hariharan S; Gunda S; Mishra GP; Pal D; Mitra AK
Pharm Res; 2009 May; 26(5):1270-82. PubMed ID: 18958406
[TBL] [Abstract][Full Text] [Related]
51. Transcellular transport of aconitine across human intestinal Caco-2 cells.
Yang C; Li Z; Zhang T; Liu F; Ruan J; Zhang Z
Food Chem Toxicol; 2013 Jul; 57():195-200. PubMed ID: 23562926
[TBL] [Abstract][Full Text] [Related]
52. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.
Yang Z; Gao S; Wang J; Yin T; Teng Y; Wu B; You M; Jiang Z; Hu M
Drug Metab Dispos; 2011 Oct; 39(10):1866-72. PubMed ID: 21757611
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the near infrared compound indocyanine green as a probe substrate of p-glycoprotein.
Portnoy E; Gurina M; Magdassi S; Eyal S
Mol Pharm; 2012 Dec; 9(12):3595-601. PubMed ID: 23098218
[TBL] [Abstract][Full Text] [Related]
55. Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein.
Zhang X; Qiu F; Jiang J; Gao C; Tan Y
Xenobiotica; 2011 Apr; 41(4):290-6. PubMed ID: 21319959
[TBL] [Abstract][Full Text] [Related]
56. Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.
Jin HE; Song B; Kim SB; Shim WS; Kim DD; Chong S; Chung SJ; Shim CK
Xenobiotica; 2013 Apr; 43(4):355-67. PubMed ID: 23020787
[TBL] [Abstract][Full Text] [Related]
57. Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions.
Grujić M; Renko M
Cancer Lett; 2002 Aug; 182(2):113-9. PubMed ID: 12048155
[TBL] [Abstract][Full Text] [Related]
58. Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor.
Huang K; Hu J; Li X; Li Y
Drug Metab Pharmacokinet; 2012; 27(5):486-94. PubMed ID: 22447116
[TBL] [Abstract][Full Text] [Related]
59. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.
Constantinides PP; Wasan KM
J Pharm Sci; 2007 Feb; 96(2):235-48. PubMed ID: 17051593
[TBL] [Abstract][Full Text] [Related]
60. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells].
Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
